Metarrestin

ML-246 · National Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Metarrestin, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors [Phase 1]